To assess the relative contribution of antiproliferative effects to the overall cytoreductive activity of brentuximab vedotin, the mean fluorescence intensity (MFI) of viable CFSE‐stained cells was obtained for CD30‐positive and CD30‐negative tumour cells (Fig. 4C). The gene discussed is TNFRSF8; the disease is neoplasm.